Tailoring the stealth properties of biocompatible polysaccharide nanocontainers

Biomaterials

Volumn 49, Issue , 2015, Pages 125-134

  Kang, Biao ^a   Okwieka, Patricia ^a,b   Schöttler, Susanne ^a   Seifert, Oliver ^c   Kontermann, Roland E ^c   Pfizenmaier, Klaus ^c   Musyanovych, Anna ^a   Meyer, Ralf ^b   Diken, Mustafa ^b,d   Sahin, Ugur ^b,d   Mailänder, Volker ^a,b   Wurm, Frederik R ^a   Landfester, Katharina ^a  

^a MAX PLANCK INSTITUTE FOR POLYMER RESEARCH   (Germany)

^b UNIVERSITY MEDICAL CENTER MAINZ   (Germany)

^c UNIVERSITY OF STUTTGART   (Germany)

^d BIONTECH AG   (Germany)

Author keywords

Hydroxyl ethyl starch; Miniemulsion; Nanocarrier; PEGylation; Stealth effect

Indexed keywords

BLOOD; NANOCAPSULES; POLYETHYLENE GLYCOLS; STARCH;

HYDROXYL ETHYL STARCHES; MINIEMULSIONS; NANOCARRIERS; PEGYLATION; STEALTH EFFECT;

BIOCOMPATIBILITY;

HETASTARCH; MACROGOL; NANOCAPSULE; NANOCARRIER; POLYSACCHARIDE; BIOMATERIAL; CYCLOHEXANE; CYCLOHEXANE DERIVATIVE; DRUG CARRIER; HETASTARCH DERIVATIVE; MACROGOL DERIVATIVE; WATER;

ADSORPTION; ARTICLE; BIOCOMPATIBILITY; CELL TRANSPORT; EMULSION; ENZYMATIC DEGRADATION; HALF LIFE TIME; PRIORITY JOURNAL; ANIMAL; BAGG ALBINO MOUSE; CHEMISTRY; CYTOLOGY; FEMALE; FLOW CYTOMETRY; HUMAN; LEUKOCYTE; MATERIALS TESTING; SYNTHESIS; TISSUE DISTRIBUTION; ULTRASTRUCTURE;

ADSORPTION; ANIMALS; BIOCOMPATIBLE MATERIALS; CYCLOHEXANES; DRUG CARRIERS; FEMALE; FLOW CYTOMETRY; HALF-LIFE; HUMANS; HYDROXYETHYL STARCH DERIVATIVES; LEUKOCYTES; MATERIALS TESTING; MICE, INBRED BALB C; NANOCAPSULES; POLYETHYLENE GLYCOLS; POLYSACCHARIDES; TISSUE DISTRIBUTION; WATER;

EID: 84924517839     PISSN: 01429612     EISSN: 18785905     Source Type: Journal    
DOI: 10.1016/j.biomaterials.2015.01.042     Document Type: Article

References (46)

1. Maxwell D.J., Taylor J.R., Nie S.M. Self-assembled nanoparticle probes for recognition and detection of biomolecules. JAm Chem Soc 2002, 124:9606-9612.
2. Vallhov H., Gabrielsson S., Stromme M., Scheynius A., Garcia-Bennett A.E. Mesoporous silica particles induce size dependent effects on human dendritic cells. Nano Lett 2007, 7:3576-3582.
3. Koppolu B., Zaharoff D.A. The effect of antigen encapsulation in chitosan particles on uptake, activation and presentation by antigen presenting cells. Biomaterials 2013, 34:2359-2369.
4. Qazilbash M.M., Brehm M., Chae B.-G., Ho P.C., Andreev G.O., Kim B.-J., et al. Mott transition in VO2 revealed by infrared spectroscopy and nano-imaging. Science 2007, 318:1750-1753.
5. Giljohann D.A., Seferos D.S., Daniel W.L., Massich M.D., Patel P.C., Mirkin C.A. Gold nanoparticles for biology and medicine. Angew Chem Int Ed 2010, 49:3280-3294.
6. Horcajada P., Chalati T., Serre C., Gillet B., Sebrie C., Baati T., et al. Porous metal-organic-framework nanoscale carriers as a potential platform for drug delivery and imaging. Nat Mater 2010, 9:172-178.
7. Min K.H., Park K., Kim Y.-S., Bae S.M., Lee S., Jo H.G., et al. Hydrophobically modified glycol chitosan nanoparticles-encapsulated camptothecin enhance the drug stability and tumor targeting in cancer therapy. JControl Release 2008, 127:208-218.
8. Vila A., Gill H., McCallion O., Alonso M.J. Transport of PLA-PEG particles across the nasal mucosa: effect of particle size and PEG coating density. JControl Release 2004, 98:231-244.
9. Laouini A., Andrieu V., Vecellio L., Fessi H., Charcosset C. Characterization of different vitamin E carriers intended for pulmonary drug delivery. Int J Pharm 2014, 471:385-390.
10. Du D., Chang N., Sun S., Li M., Yu H., Liu M., et al. The role of glucose transporters in the distribution of p-aminophenyl-alpha-D-mannopyranoside modified liposomes within mice brain. JControl Release 2014, 182:99-110.
11. Yamada Y., Tabata M., Yasuzaki Y., Nomura M., Shibata A., Ibayashi Y., et al. Ananocarrier system for the delivery of nucleic acids targeted to a pancreatic beta cell line. Biomaterials 2014, 35:6430-6438.
12. Ju R.-J., Li X.-T., Shi J.-F., Li X.-Y., Sun M.-G., Zeng F., et al. Liposomes, modified with PTDHIV-1 peptide, containing epirubicin and celecoxib, to target vasculogenic mimicry channels in invasive breast cancer. Biomaterials 2014, 35:7610-7621.
13. Ara M.N., Matsuda T., Hyodo M., Sakurai Y., Hatakeyama H., Ohga N., et al. An aptamer ligand based liposomal nanocarrier system that targets tumor endothelial cells. Biomaterials 2014, 35:7110-7120.
14. Guo Z., He B., Jin H., Zhang H., Dai W., Zhang L., et al. Targeting efficiency of RGD-modified nanocarriers with different ligand intervals in response to integrin alpha v beta 3 clustering. Biomaterials 2014, 35:6106-6117.
15. Zhang X., Zhang Q., Peng Q., Zhou J., Liao L., Sun X., et al. Hepatitis B virus preS1-derived lipopeptide functionalized liposomes for targeting of hepatic cells. Biomaterials 2014, 35:6130-6141.
16. Qin C., He B., Dai W., Lin Z., Zhang H., Wang X., et al. The impact of a chlorotoxin-modified liposome system on receptor MMP-2 and the receptor-associated protein ClC-3. Biomaterials 2014, 35:5908-5920.
17. Kuo Y.-C., Wang C.-T. Protection of SK-N-MC cells against beta-amyloid peptide-induced degeneration using neuron growth factor-loaded liposomes with surface lactoferrin. Biomaterials 2014, 35:5954-5964.
18. Miyabe H., Hyodo M., Nakamura T., Sato Y., Hayakawa Y., Harashima H. Anew adjuvant delivery system 'cyclic di-GMP/YSK05 liposome' for cancer immunotherapy. JControl Release 2014, 184:20-27.
19. Liu Z., Xiong M., Gong J., Zhang Y., Bai N., Luo Y., et al. Legumain protease-activated TAT-liposome cargo for targeting tumours and their microenvironment. Nat Commun 2014, 5.
20. Qhattal H.S.S., Hye T., Alali A., Liu X. Hyaluronan polymer length, grafting density, and surface poly(ethylene glycol) coating influence invivo circulation and tumor targeting of Hyaluronan-grafted liposomes. ACS Nano 2014, 8:5423-5440.
21. She Z., Zhang T., Wang X., Li X., Song Y., Cheng X., et al. The anticancer efficacy of pixantrone-loaded liposomes decorated with sialic acid-octadecylamine conjugate. Biomaterials 2014, 35:5216-5225.
22. Cheng Z., Al Zaki A., Hui J.Z., Muzykantov V.R., Tsourkas A. Multifunctional nanoparticles: cost versus benefit of adding targeting and imaging capabilities. Science 2012, 338:903-910.
23. Davis M.E., Chen Z., Shin D.M. Nanoparticle therapeutics: an emerging treatment modality for cancer. Nat Rev Drug Discov 2008, 7:771-782.
24. Yan Y., Such G.K., Johnston A.P.R., Best J.P., Caruso F. Engineering particles for therapeutic delivery: prospects and challenges. ACS Nano 2012, 6:3663-3669.
25. Brannon-Peppas L., Blanchette J.O. Nanoparticle and targeted systems for cancer therapy. Adv Drug Deliv Rev 2004, 56:1649-1659.
26. Landfester K. Miniemulsion polymerization and the structure of polymer and hybrid nanoparticles. Angew Chem Int Ed 2009, 48:4488-4507.
27. Landfester K., Bechthold N., Tiarks F., Antonietti M. Formulation and stability mechanisms of polymerizable miniemulsions. Macromolecules 1999, 32:5222-5228.
28. Baier G., Musyanovych A., Dass M., Theisinger S., Landfester K. Cross-linked starch capsules containing dsDNA prepared in inverse miniemulsion as "Nanoreactors" for polymerase chain reaction. Biomacromolecules 2010, 11:960-968.
29. Lv L.-P., Zhao Y., Vilbrandt N., Gallei M., Vimalanandan A., Rohwerder M., et al. Redox responsive release of hydrophobic self-healing agents from polyaniline capsules. JAm Chem Soc 2013, 135:14198-14205.
30. Siebert J.M., Baier G., Musyanovych A., Landfester K. Towards copper-free nanocapsules obtained by orthogonal interfacial "click" polymerization in miniemulsion. Chem Commun 2012, 48:5470-5472.
31. Zarychanski R., Abou-Setta A.M., Turgeon A.F., Houston B.L., McIntyre L., Marshall J.C., et al. Association of hydroxyethyl starch administration with mortality and acute kidney injury in critically Ill patients requiring volume resuscitation a systematic review and meta-analysis. JAm Med Assoc 2013, 309:678-688.
32. Yoshida M., Kishikawa T. Astudy of hydroxyethyl starch 2. Degradation-sites of hydroxyethyl starch by pig pancreas alpha-amylase. Starke 1984, 36:167-169.
33. Noga M., Edinger D., Klaeger R., Wegner S.V., Spatz J.P., Wagner E., et al. The effect of molar mass and degree of hydroxyethylation on the controlled shielding and deshielding of hydroxyethyl starch-coated polyplexes. Biomaterials 2013, 34:2530-2538.
34. Noga M., Edinger D., Roedl W., Wagner E., Winter G., Besheer A. Controlled shielding and deshielding of gene delivery polyplexes using hydroxyethyl starch (HES) and alpha-amylase. JControl Release 2012, 159:92-103.
35. Schlaad H., Kukula H., Rudloff J., Below I. Synthesis of alpha, omega-heterobifunctional poly(ethylene glycol)s by metal-free anionic ring-opening polymerization. Macromolecules 2001, 34:4302-4304.
36. Bohlen P., Stein S., Dairman W., Udenfrie S. Fluorometric assay of proteins in nanogram range. Arch Biochem Biophys 1973, 155:213-220.
37. Stolnik S., Illum L., Davis S.S. Long circulating microparticulate drug carriers. Adv Drug Deliv Rev 1995, 16:195-214.
38. Baier G., Baumann D., Siebert J.M., Musyanovych A., Mailaender V., Landfester K. Suppressing unspecific cell uptake for targeted delivery using hydroxyethyl starch nanocapsules. Biomacromolecules 2012, 13:2704-2715.
39. Cedervall T., Lynch I., Lindman S., Berggard T., Thulin E., Nilsson H., et al. Understanding the nanoparticle-protein corona using methods to quantify exchange rates and affinities of proteins for nanoparticles. Proc Natl Acad Sci U S A 2007, 104:2050-2055.
40. Aggarwal P., Hall J.B., McLeland C.B., Dobrovolskaia M.A., McNeil S.E. Nanoparticle interaction with plasma proteins as it relates to particle biodistribution, biocompatibility and therapeutic efficacy. Adv Drug Deliv Rev 2009, 61:428-437.
41. Walczyk D., Bombelli F.B., Monopoli M.P., Lynch I., Dawson K.A. What the cell "sees" in bionanoscience. JAm Chem Soc 2010, 132:5761-5768.
42. Roecker C., Poetzl M., Zhang F., Parak W.J., Nienhaus G.U. Aquantitative fluorescence study of protein monolayer formation on colloidal nanoparticles. Nat Nanotech 2009, 4:577-580.
43. Deng Z.J., Liang M., Monteiro M., Toth I., Minchin R.F. Nanoparticle-induced unfolding of fibrinogen promotes Mac-1 receptor activation and inflammation. Nat Nanotech 2011, 6:39-44.
44. Walkey C.D., Chan W.C.W. Understanding and controlling the interaction of nanomaterials with proteins in a physiological environment. Chem Soc Rev 2012, 41:2780-2799.
45. Monopoli M.P., Walczyk D., Campbell A., Elia G., Lynch I., Bombelli F.B., et al. Physical-chemical aspects of protein corona: relevance to invitro and invivo biological impacts of nanoparticles. JAm Chem Soc 2011, 133:2525-2534.
46. Albanese A., Walkey C.D., Olsen J.B., Guo H., Emili A., Chan W.C.W. Secreted biomolecules alter the biological identity and cellular interactions of nanoparticles. ACS Nano 2014, 8:5515-5526.